Condition 1: Pain severity. Condition 2: Wound healing. Other acute post procedural pain Disruption of peritoneal obstetric wound
Conditions
Interventions
Astragalus fasciculifolius Cream 10%: This herbal cream (Astragalus fasciculifolius plant), based on Vaseline and 10% active substance concentration, will be made by a traditional medicine doctor in
Phenytoin Cream 1%: Phenytoin cream 1% is produced by Amin Pharmaceutical Company. It is filled in a 60 mg white tube by a traditional medicine doctor for the purpose of blinding (like the tubes of ot
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Normal pregnancy and delivery primiparous Age between 15-45 Having at least reading and writing literacy Body mass index (after delivery) between 18.5-30 kilograms per square meter
Exclusion criteria
Exclusion criteria: Gestational age below 37 or above 42 weeks Multiple pregnancy Fetus Malpresentation Suffering from diseases that interfere with wound healing such as: anemia, infection and perineum wounds, diabetes, High blood pressure, diseases of skin, heart, kidney, lung , coagulation disorder, immunodeficiency, hemophilia, disorder of connective tissue, depression, malnutrition, mental illnesses, cancer) Using drugs effective on wound healing such as: anticoagulants, antidepressants, antiepileptics), glucocorticoids, immune system suppressors, antibiotics, narcotics and psychotropic drugs, chemotherapy Rupture of Amionitic membran more than 18 hours Instrumental vaginal delivery or non-medial or lateral episiotomy incision Non spontaneous removal of the placenta History of previous injury or surgery or visible lesions in the perineum such as: genital warts, hemorrhoids Alcohol drinking or smoking Persistent constipation (according to the mother statement )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Days1, 5 and 10 after delivery. Method of measurement: Visual analog scale (VAS).;Episiotomy wound healing. Timepoint: Days1, 5 and 10 after delivery. Method of measurement: Reeda Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effect. Timepoint: Days 5 and 10 after delivery. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Fereshteh Farzanazar
Arak University of Medical Sciences
Outcome results
None listed